CagriSema is an investigational weight loss injection combining semaglutide 2.4 mg (a GLP-1 agonist, the drug in Wegovy) and cagrilintide 2.4 mg (an amylin analogue)
Monitoring parameters during treatment should include regular assessment of therapeutic response, adverse effects, and relevant laboratory parameters
B-Complex Vitamin IV therapy may potentially benefit individuals experiencing age-related cognitive decline by providing the necessary nutrients to support brain health, enhance memory, and promote cognitive performance
For now, retatrutide remains in clinical trials with uncertain approval timeline
DA reduces the inflammation in human inflammatory bowel disease
48 The therapeutic utility of PRP in the context of cartilage regeneration has garnered significant recognition, attributed to its capacity to mitigate catabolism while concurrently amplifying the anabolic milieu within the hyaline cartilage environment